Nicole Donnellan

No ORCID on file · 58 papers in corpus · active 2011-2026

Study types

  • preprint 26
  • article 24
  • book-chapter 2
  • other 2
  • review 2

Condition tags

  • endometriosis 52
  • chronic_pelvic_pain 10
  • adenomyosis 2
  • dysmenorrhea 2
  • bladder_endometriosis 1
  • endometrioma 1
  • die_deep_infiltrating 1
  • dyspareunia 1
other 2026
Molecular human reproduction ·doi:10.1093/molehr/gaaf061

Endometriosis (EM) is a debilitating disease involving the growth of endometrial glands and stroma outside the uterus. To further our understanding of epigenomic dysregulation in EM and search for disease biomarkers, we performed a comprehe…

article 2026
·doi:10.1177/10424067261451104

Objective: The objective of this study is to determine whether patients who are diagnosed with ovarian endometrioma(s) on imaging undergo fewer total surgeries for treatment of their endometrioma and endometriosis if the initial surgery is …

article 2025
·doi:10.1097/aog.0000000000005851.59

INTRODUCTION: Definitive surgical management of severe endometriosis involves excision with hysterectomy and bilateral salpingo-oophorectomy (BSO). Women who are less than 50 years old at the time of BSO have an increased morbidity, includi…

article 2025
·doi:10.1158/0008-5472.30699610

Supplementary figures and table

article 2025
·doi:10.1016/j.jpain.2025.104802
article 2024
·doi:10.1016/j.jmig.2024.09.996
preprint 2023
·doi:10.1158/1078-0432.c.6522953.v1

AbstractPurpose: Mechanisms of immune dysregulation associated with advanced tumors are relatively well understood. Much less is known about the role of immune effectors against cancer precursor lesions. Endometrioid and clear-cell ovarian …

preprint 2023
·doi:10.1158/1078-0432.c.6522953

AbstractPurpose: Mechanisms of immune dysregulation associated with advanced tumors are relatively well understood. Much less is known about the role of immune effectors against cancer precursor lesions. Endometrioid and clear-cell ovarian …

preprint 2023
·doi:10.1158/0008-5472.c.6514212.v1

AbstractOvarian clear cell carcinoma (OCCC) is a deadly and treatment-resistant cancer, which arises within the unique microenvironment of endometriosis. In this study, we identified a subset of endometriosis-derived mesenchymal stem cells …

preprint 2023
·doi:10.1158/0008-5472.c.6514212

AbstractOvarian clear cell carcinoma (OCCC) is a deadly and treatment-resistant cancer, which arises within the unique microenvironment of endometriosis. In this study, we identified a subset of endometriosis-derived mesenchymal stem cells …

preprint 2023
·doi:10.1158/1078-0432.c.6521559.v1

AbstractPurpose: Endometriosis, a largely benign, chronic inflammatory disease, is an independent risk factor for endometrioid and clear cell epithelial ovarian tumors. We aimed to identify plasma miRNAs that can be used to differentiate pa…

preprint 2023
·doi:10.1158/1078-0432.c.6521559

AbstractPurpose: Endometriosis, a largely benign, chronic inflammatory disease, is an independent risk factor for endometrioid and clear cell epithelial ovarian tumors. We aimed to identify plasma miRNAs that can be used to differentiate pa…

preprint 2023
·doi:10.1158/0008-5472.22432671

Supplementary figures and table

preprint 2023
·doi:10.1158/0008-5472.22432671.v1

Supplementary figures and table

preprint 2023
·doi:10.1158/1078-0432.22449093

PDF file - 488K, Supplementary Figure 1: Experimental design. Supplementary Figure 2. Reliability of RNA extraction and reproducibility of RTqPCR techniques. Supplementary Figure 3. Reliability of RT-qPCR assays. Supplementary Figure 4. miR…

preprint 2023
·doi:10.1158/1078-0432.22449093.v1

PDF file - 488K, Supplementary Figure 1: Experimental design. Supplementary Figure 2. Reliability of RNA extraction and reproducibility of RTqPCR techniques. Supplementary Figure 3. Reliability of RT-qPCR assays. Supplementary Figure 4. miR…

preprint 2023
·doi:10.1158/1078-0432.22455170

Supplementary Materials and Methods

preprint 2023
·doi:10.1158/1078-0432.22455170.v1

Supplementary Materials and Methods

supplementary-materials 2023
·doi:10.1158/1078-0432.22449087.v1

PDF file - 36K, Supplementary Table 1. Demographic and clinical characteristics of the study cohort. Supplementary Table 2. List of the 24 miRNAs identified by genome-wide plasma miRNA expression profiling from healthy controls (n=6), endom…

supplementary-materials 2023
·doi:10.1158/1078-0432.22449087

PDF file - 36K, Supplementary Table 1. Demographic and clinical characteristics of the study cohort. Supplementary Table 2. List of the 24 miRNAs identified by genome-wide plasma miRNA expression profiling from healthy controls (n=6), endom…

preprint 2023
·doi:10.1158/1078-0432.22455191

Suppl Fig S1. Venn diagram of DE genes from 3 group comparisons

preprint 2023
·doi:10.1158/1078-0432.22455191.v1

Suppl Fig S1. Venn diagram of DE genes from 3 group comparisons

preprint 2023
·doi:10.1158/1078-0432.22455188

Suppl Fig S2. Kras and Pten pathways in relationship to complement gene expression

preprint 2023
·doi:10.1158/1078-0432.22455188.v1

Suppl Fig S2. Kras and Pten pathways in relationship to complement gene expression

preprint 2023
·doi:10.1158/1078-0432.22455185.v1

Suppl Fig S3. Antibody-mediated, complement-induced cytotoxicity